Evidence map›Paper›PMID 36497976›Full record

Observational studyInternational journal of environmental research and public health2022

Comprehensive Multimorbidity Patterns in Older Patients Are Associated with Quality Indicators of Medication-MoPIM Cohort Study.

Marina Lleal, Marisa Baré, Sara Ortonobes, Daniel Sevilla-Sánchez, Rosa Jordana, Susana Herranz, Maria Queralt Gorgas, Mariona Espaulella-Ferrer, Marta Arellano, Marta de Antonio and 3 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02830425 (Potentially Inappropriate Prescription Associated to Multimorbidity, Using the Explicit STOPP-START), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02830425 completednot on this map

Potentially Inappropriate Prescription Associated to Multimorbidity, Using the Explicit STOPP-START (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert Doctors to the Right Treatment) Criteria

TypeobservationalSponsorCorporacion Parc TauliRan2016 to 2019Enrolled740ConditionsChronic DiseaseArmsNo intervention
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Observational
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Marina LlealInstitutional Committee for the Improvement of Clinical Practice Adequacy, Clinical Epidemiology and Cancer Screening Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.ORCID 0000-0002-0015-0725
Marisa BaréInstitutional Committee for the Improvement of Clinical Practice Adequacy, Clinical Epidemiology and Cancer Screening Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.ORCID 0000-0001-8085-2833
Sara OrtonobesPharmacy Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
Daniel Sevilla-SánchezPharmacy Department, Parc Sanitari Pere Virgili, 08023 Barcelona, Catalonia, Spain.ORCID 0000-0003-2993-6200
Rosa JordanaInternal Medicine Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
Susana HerranzAcute Care Geriatric Unit, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
Maria Queralt GorgasPharmacy Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
Mariona Espaulella-FerrerGeriatrics Department, Consorci Hospitalari de Vic, 08500 Vic, Catalonia, Spain.ORCID 0000-0003-3416-7792
Marta ArellanoGeriatrics Department, Consorci Parc de Salut MAR, 08003 Barcelona, Catalonia, Spain.
Marta de AntonioPharmacy Department, Consorci Parc de Salut MAR, 08003 Barcelona, Catalonia, Spain.
Gloria Julia NazcoPharmacy Department, Hospital Universitario de Canarias, 38320 La Laguna, Canarias, Spain.
Rubén Hernández-LuisInternal Medicine Department, Hospital Universitario de Canarias, 38320 La Laguna, Canarias, Spain.
On Behalf Of The MoPIM Study Group
Corporació Sanitària Parc Taulí · ESHospital Universitario de Canarias · ESParc de Salut · ESHospital Universitari de Vic · ESInstituto de Salud Carlos III · ESParque Sanitario Pere Virgili · ESUniversitat Autònoma de Barcelona · ES

Funding

Instituto de Salud Carlos III PI15/00552Network for Research into Healthcare in Chronic Diseases (REDISSEC) RD16/0001/0002
6 · The paper itself

Abstract

Multimorbidity is increasing and poses a challenge to the clinical management of patients with multiple conditions and drug prescriptions. The objectives of this work are to evaluate if multimorbidity patterns are associated with quality indicators of medication: potentially inappropriate prescribing (PIP) or adverse drug reactions (ADRs). A multicentre prospective cohort study was conducted including 740 older (≥65 years) patients hospitalised due to chronic pathology exacerbation. Sociodemographic, clinical and medication related variables (polypharmacy, PIP according to STOPP/START criteria, ADRs) were collected. Bivariate analyses were performed comparing previously identified multimorbidity clusters (osteoarticular, psychogeriatric, minor chronic disease, cardiorespiratory) to presence, number or specific types of PIP or ADRs. Significant associations were found in all clusters. The osteoarticular cluster presented the highest prevalence of PIP (94.9%) and ADRs (48.2%), mostly related to anxiolytics and antihypertensives, followed by the minor chronic disease cluster, associated with ADRs caused by antihypertensives and insulin. The psychogeriatric cluster presented PIP and ADRs of neuroleptics and the cardiorespiratory cluster indicators were better overall. In conclusion, the associations that were found reinforce the existence of multimorbidity patterns and support specific medication review actions according to each patient profile. Thus, determining the relationship between multimorbidity profiles and quality indicators of medication could help optimise healthcare processes. Trial registration number: NCT02830425.

Indexed as

Drug-Related Side Effects and Adverse ReactionsQuality Indicators, Health CareAgedChronic DiseaseCohort StudiesHumansInappropriate PrescribingMultimorbidityPotentially Inappropriate Medication ListProspective Studiesadverse drug reactioncluster analysishealthcare quality indicatormultimorbidityolder patientpolypharmacypotentially inappropriate medicationpotential prescribing omission

Identifiers

PMID36497976
PMCPMC9739326
OpenAlexW4310995019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.